Jeffrey S. Hackman

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Woburn, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jeffrey Hackman
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jeffrey S. Hackman

Form 4 holding Chief Executive Officer, Director

FENNEC PHARMACEUTICALS INC.

Security class
Stock Options
Shares / value
725,000
Estimated value
$1,412,250
Report date
31 Mar 2026
Price
$2.69
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chairman, President, and Chief Executive Officer., Director

Comera Life Sciences Holdings, Inc.

Security class
Stock Option (Right to Purchase)
Shares / value
600,000
Estimated value
Report date
27 Sep 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

FENNEC PHARMACEUTICALS INC.

Security class
Restricted Share Unit
Shares / value
475,000
Estimated value
Report date
28 Mar 2025
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount

Insider Reports Filed by Jeffrey S. Hackman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .